Wesdome Gold Mines Ltd. (0VOA)
London Stock Exchange · UK · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 28.20 |
|---|---|
| 52-week range | 20.06 – 36.72 |
| Return, 1 month / 3 months | −22.6% / +7.0% |
| Return, 1 year / 3 years | +38.2% / +252.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 57.2% |
| Worst drawdown (1 year) | -24.6% |
| Average daily value traded | 0.06M CAD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wesdome Gold Mines Ltd. is a Canadian gold mining company that explores for, develops and produces gold. Its operations are concentrated in Ontario and Quebec, where it runs underground gold mines and a related milling complex. The company processes ore at its own facilities and produces gold doré, which is refined further before reaching precious metals markets. Wesdome is based in Toronto, Canada, and its activities span mining, mineral processing and ongoing exploration around its existing mine sites.
On this site Wesdome Gold Mines Ltd. appears as a stock on the London Stock Exchange (UK), code 0VOA, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wesdome Gold Mines Ltd. (0VOA) trades on the London Stock Exchange in UK. It last closed at CAD 28.20 on 27 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 2,137 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.2% and over the last three months it rose 7.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.8% | ||
| From 52-week high | -23.1% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.0% | ||
| 6-month return | 6.3% | ||
| 12-month return, skipping the last month | 78.4% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.6% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 1 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 1 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.0% |
|---|---|
| 1 month | −22.6% |
| 3 months | +7.0% |
| 6 months | +6.3% |
| 1 year | +38.2% |
| 3 years | +252.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 33.39 / 27.70 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | CAD 0.0306 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.